Biological Insights into Chemotherapy Resistance in Ovarian Cancer

The majority of patients with high-grade serous ovarian cancer (HGSOC) initially respond to chemotherapy; however, most will develop chemotherapy resistance. Gene signatures may change with the development of chemotherapy resistance in this population, which is important as it may lead to tailored t...

Descripción completa

Detalles Bibliográficos
Autores principales: Glasgow, Michelle A., Argenta, Peter, Abrahante, Juan E., Shetty, Mihir, Talukdar, Shobhana, Croonquist, Paula A., Khalifa, Mahmoud A., Starr, Timothy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547356/
https://www.ncbi.nlm.nih.gov/pubmed/31052165
http://dx.doi.org/10.3390/ijms20092131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547356/
https://www.ncbi.nlm.nih.gov/pubmed/31052165
http://dx.doi.org/10.3390/ijms20092131

Ejemplares similares